Samphire Neuroscience: Funding, Investors & Team (Oct 2026)
Samphire Neuroscience offers specialized solutions for women's health and was established in London, England in 2021.
Samphire Neuroscience has raised $7.3M across 3 funding rounds on record, the most recent a Seed of $5.0M announced in Jun 2025.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Samphire Neuroscience Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Samphire Neuroscience Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Samphire Neuroscience announced a Pre-Seed in Dec 2023; the amount was not disclosed.
2 months later, a Pre-Seed of $2.3M was announced in Feb 2024.
1.3 years later, a Seed of $5.0M was announced in Jun 2025.
Samphire Neuroscience Founders and Leadership Team
No contact details are on record for this team yet.
Samphire Neuroscience Funding Compared to Other Biotechnology Startups
Samphire Neuroscience's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Samphire Neuroscience in Biotechnology and London
Companies Similar to Samphire Neuroscience
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Samphire Neuroscience Funding FAQs
What does Samphire Neuroscience do?
Samphire Neuroscience offers specialized solutions for women's health and was established in London, England in 2021.
How much funding has Samphire Neuroscience raised?
Samphire Neuroscience has raised $7.3M across 3 rounds on record. The most recent is a Seed of $5.0M announced in Jun 2025.
When did Samphire Neuroscience last raise funding?
Samphire Neuroscience's most recent funding round on record is a Seed of $5.0M, announced in Jun 2025.
Who founded Samphire Neuroscience?
FundedIQ lists Emile R (Founder), Emile Radyte (Founder) at Samphire Neuroscience.
Where is Samphire Neuroscience headquartered?
Samphire Neuroscience is based in London, England, United Kingdom.
How many employees does Samphire Neuroscience have?
Samphire Neuroscience is in the 11-50 employee band.
How does Samphire Neuroscience's funding compare to other Biotechnology startups?
Samphire Neuroscience's latest round of $5.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Samphire Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Samphire Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.